Literature DB >> 16894516

What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?

Anthony D Harris1, Jessina C McGregor, Jon P Furuno.   

Abstract

Multidrug-resistant gram-negative bacteria are an emerging problem. The present article addresses 2 relevant questions: (1) should active surveillance be performed to identify patients colonized with multidrug-resistant gram-negative bacteria, and (2) should contact isolation precautions be taken with patients colonized or infected with multidrug-resistant gram-negative bacteria? Data and variables that are needed to scientifically answer these questions are reviewed, as are existing data on Pseudomonas aeruginosa, Enterobacteriaceae (Escherichia coli and Klebsiella species in particular), and Acinetobacter baumannii.

Entities:  

Mesh:

Year:  2006        PMID: 16894516     DOI: 10.1086/504479

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

Review 1.  Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations of an expert panel of the German Society For Hygiene and Microbiology.

Authors:  Frauke Mattner; Franz-C Bange; Elisabeth Meyer; Harald Seifert; Thomas A Wichelhaus; Iris F Chaberny
Journal:  Dtsch Arztebl Int       Date:  2012-01-20       Impact factor: 5.594

Review 2.  Acinetobacter pneumonia: a review.

Authors:  Joshua D Hartzell; Andrew S Kim; Mark G Kortepeter; Kimberly A Moran
Journal:  MedGenMed       Date:  2007-07-05

3.  Risk factors for multidrug-resistant Pseudomonas aeruginosa acquisition. Impact of antibiotic use in a double case-control study.

Authors:  M Montero; M Sala; M Riu; F Belvis; M Salvado; S Grau; J P Horcajada; F Alvarez-Lerma; R Terradas; M Orozco-Levi; X Castells; H Knobel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-24       Impact factor: 3.267

Review 4.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Sensitivity of surveillance testing for multidrug-resistant Gram-negative bacteria in the intensive care unit.

Authors:  Jessica P Ridgway; Lance R Peterson; Richard B Thomson; Becky A Miller; Marc-Oliver Wright; Donna M Schora; Ari Robicsek
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

6.  UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study.

Authors:  Karim Makdoumi; Jes Mortensen; Omid Sorkhabi; Bo-Eric Malmvall; Sven Crafoord
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-27       Impact factor: 3.117

7.  Patterns of ciprofloxacin-resistant gram-negative bacteria colonization in nursing home residents.

Authors:  Parimala Dommeti; Linda Wang; Erika L Flannery; Kathleen Symons; Lona Mody
Journal:  Infect Control Hosp Epidemiol       Date:  2011-02       Impact factor: 3.254

8.  Multidrug-resistant gram-negative bacteria among patients who require chronic hemodialysis.

Authors:  Aurora Pop-Vicas; James Strom; Karen Stanley; Erika M C D'Agata
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-05       Impact factor: 8.237

9.  Comparison of PCR/electron spray ionization-time-of-flight-mass spectrometry versus traditional clinical microbiology for active surveillance of organisms contaminating high-use surfaces in a burn intensive care unit, an orthopedic ward and healthcare workers.

Authors:  Heather C Yun; Rachael E Kreft; Mayra A Castillo; Garth D Ehrlich; Charles H Guymon; Helen K Crouch; Kevin K Chung; Joseph C Wenke; Joseph R Hsu; Tracy L Spirk; J William Costerton; Katrin Mende; Clinton K Murray
Journal:  BMC Infect Dis       Date:  2012-10-10       Impact factor: 3.090

10.  Antimicrobial drug use and antibiotic-resistant bacteria.

Authors:  Fernando Bellissimo-Rodrigues
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.